{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:45:12Z","timestamp":1776390312052,"version":"3.51.2"},"reference-count":106,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.rmr.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T10:17:25Z","timestamp":1706091445000},"page":"156-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Complications pulmonaires de la granulomatose septique chronique"],"prefix":"10.1016","volume":"41","author":[{"given":"H.","family":"Salvator","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mahlaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Marcais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Longchampt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tcherakian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Givel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chabrol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Caradec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Goyard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.J.","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Catherinot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2024.01.002_bib0535","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019\u00a0update of the IUIS Phenotypical Classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0540","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaip.2016.03.021","article-title":"A comprehensive approach to the management of children and adults with chronic granulomatous disease","volume":"4","author":"Thomsen","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2024.01.002_bib0545","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajh.24573","article-title":"Chronic granulomatous disease: clinical, functional, molecular, and genetic studies. The Israeli experience with 84\u00a0patients","volume":"92","author":"Wolach","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0550","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368\u00a0patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2024.01.002_bib0555","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1093\/jpids\/piy008","article-title":"Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease","volume":"7","author":"Rider","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.rmr.2024.01.002_bib0560","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jaci.2018.12.994","article-title":"Genetic diagnosis of primary immunodeficiencies: a survey of the French national registry","volume":"143","author":"Mahlaoui","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0565","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/INF.0b013e3181f13b23","article-title":"Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France","volume":"30","author":"Beaut\u00e9","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.rmr.2024.01.002_bib0570","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(96)90403-1","article-title":"Chronic granulomatous disease in adults","volume":"347","author":"Liese","year":"1996","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.rmr.2024.01.002_bib0575","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10875-017-0370-1","article-title":"Respiratory complications lead to the diagnosis of chronic granulomatous disease in two adult patients","volume":"37","author":"Colin de Verdi\u00e8re","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0580","first-page":"309","article-title":"A fatal granulomatosus of childhood: the clinical study of a new syndrome","volume":"40","author":"Berendes","year":"1957","journal-title":"Minn Med"},{"key":"10.1016\/j.rmr.2024.01.002_bib0585","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cid\/ciw837","article-title":"Chronic granulomatous disease in patients reaching adulthood: a nationwide study in France","volume":"64","author":"Dunogu\u00e9","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2024.01.002_bib0590","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.20161382","article-title":"Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity","volume":"214","author":"Thomas","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.rmr.2024.01.002_bib0595","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.rmr.2024.01.002_bib0600","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2019.04.014","article-title":"Tamoxifen restores extracellular trap formation in neutrophils from patients with chronic granulomatous disease in a reactive oxygen species-independent manner","volume":"144","author":"Sharma","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0605","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fcimb.2017.00373","article-title":"Neutrophils to the ROScue: mechanisms of NADPH oxidase activation and bacterial resistance","volume":"7","author":"Nguyen","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0610","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fimmu.2014.00448","article-title":"Granule protein processing and regulated secretion in neutrophils","volume":"5","author":"Sheshachalam","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0615","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.imlet.2020.02.009","article-title":"Beyond bacterial killing: NADPH oxidase 2\u00a0is an immunomodulator","volume":"221","author":"Trevelin","year":"2020","journal-title":"Immunol Lett"},{"key":"10.1016\/j.rmr.2024.01.002_bib0620","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1073\/pnas.0914795107","article-title":"Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease","volume":"107","author":"van de Veerdonk","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rmr.2024.01.002_bib0625","unstructured":"Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease\u00a0\u2013\u00a0PubMed [Internet]. [cit\u00e9 22\u00a0nov 2021]. Disponible sur\u00a0: https:\/\/pubmed.ncbi.nlm.nih.gov\/20495074\/."},{"key":"10.1016\/j.rmr.2024.01.002_bib0630","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/978-1-4939-9424-3_33","article-title":"Diagnostic testing for chronic granulomatous disease","volume":"1982","author":"Kuhns","year":"2019","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"10.1016\/j.rmr.2024.01.002_bib0635","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2024.01.002_bib0640","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s10875-021-01055-x","article-title":"Clinical features of female Taiwanese carriers with X-linked chronic granulomatous disease from 2004\u00a0to 2019","volume":"41","author":"Wu","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0645","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clim.2003.08.002","article-title":"Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation","volume":"109","author":"Anderson-Cohen","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0650","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaci.2017.04.035","article-title":"X-linked carriers of chronic granulomatous disease: illness, lyonization, and stability","volume":"141","author":"Marciano","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0655","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10875-013-9899-9","article-title":"Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease","volume":"33","author":"Wang","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0660","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12016-009-8136-z","article-title":"Chronic granulomatous disease","volume":"38","author":"Holland","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0665","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/422993","article-title":"Long-term interferon-gamma therapy for patients with chronic granulomatous disease","volume":"39","author":"Marciano","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2024.01.002_bib0670","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","article-title":"Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study","volume":"126","author":"Martire","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0675","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jaci.2020.08.034","article-title":"Long-term outcomes for adults with chronic granulomatous disease in the United Kingdom","volume":"147","author":"Campos","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0680","doi-asserted-by":"crossref","first-page":"e5234","DOI":"10.1371\/journal.pone.0005234","article-title":"Chronic granulomatous disease: the European experience","volume":"4","author":"van den Berg","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2024.01.002_bib0685","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.2008.03644.x","article-title":"Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry","volume":"152","author":"Jones","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0690","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1442-200x.1999.01129.x","article-title":"Chronic granulomatous disease in Japan: incidence and natural history. The Study Group of Phagocyte Disorders of Japan","volume":"41","author":"Hasui","year":"1999","journal-title":"Pediatr Int"},{"key":"10.1016\/j.rmr.2024.01.002_bib0695","doi-asserted-by":"crossref","first-page":"625320","DOI":"10.3389\/fimmu.2021.625320","article-title":"Clinical, immunological, and molecular profile of chronic granulomatous disease: a multi-centric study of 236\u00a0patients from India","volume":"12","author":"Rawat","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0700","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaci.2013.05.039","article-title":"Clinical, functional, and genetic characterization of chronic granulomatous disease in 89\u00a0Turkish patients","volume":"132","author":"K\u00f6ker","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0705","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10875-020-00750-5","article-title":"Genetic, immunological, and clinical features of the first Mexican cohort of patients with chronic granulomatous disease","volume":"40","author":"Blancas-Galicia","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0710","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","article-title":"Common severe infections in chronic granulomatous disease","volume":"60","author":"Marciano","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2024.01.002_bib0715","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1093\/cid\/cir731","article-title":"Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey","volume":"53","author":"Blumental","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2024.01.002_bib0720","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/JCM.01509-12","article-title":"Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy","volume":"50","author":"Sugui","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0725","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-199809000-00004","article-title":"Aspergillus nidulans infection in chronic granulomatous disease","volume":"77","author":"Segal","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2024.01.002_bib0730","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1080\/13693780902736620","article-title":"Invasive aspergillosis in chronic granulomatous disease","volume":"47","author":"Segal","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0735","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1183\/09031936.00118414","article-title":"Pulmonary manifestations in adult patients with chronic granulomatous disease","volume":"45","author":"Salvator","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2024.01.002_bib0740","doi-asserted-by":"crossref","first-page":"19349","DOI":"10.1038\/s41598-020-76408-4","article-title":"Imaging findings of pulmonary manifestations of chronic granulomatous disease in a large single center from Shanghai, China (1999\u20132018)","volume":"10","author":"Yao","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.rmr.2024.01.002_bib0745","first-page":"1183","article-title":"Imaging of chronic granulomatous disease in children","volume":"25","author":"Khanna","year":"2005","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"10.1016\/j.rmr.2024.01.002_bib0750","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1586\/1744666X.5.1.45","article-title":"Chronic granulomatous disease: complications and management","volume":"5","author":"Rosenzweig","year":"2009","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0755","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00281-008-0119-2","article-title":"Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase","volume":"30","author":"Sch\u00e4ppi","year":"2008","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0760","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1463-1318.2006.01030.x","article-title":"Gastrointestinal manifestations of chronic granulomatous disease","volume":"8","author":"Huang","year":"2006","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.rmr.2024.01.002_bib0765","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.114.2.462","article-title":"Gastrointestinal involvement in chronic granulomatous disease","volume":"114","author":"Marciano","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2024.01.002_bib0770","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11894-016-0491-3","article-title":"Gastrointestinal disorders associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD)","volume":"18","author":"Uzzan","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.rmr.2024.01.002_bib0775","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.iac.2018.08.006","article-title":"Gastrointestinal manifestations and complications of primary immunodeficiency disorders","volume":"39","author":"Agarwal","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.rmr.2024.01.002_bib0780","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/pai.12814","article-title":"Inflammatory bowel disease in chronic granulomatous disease: an emerging problem over a twenty years\u2019 experience","volume":"28","author":"Angelino","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0785","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ajg.2008.72","article-title":"Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease","volume":"104","author":"Marks","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0790","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00043426-200403000-00014","article-title":"Recurrent eosinophilic cystitis in a child with chronic granulomatous disease","volume":"26","author":"Barese","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0795","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0022-3476(99)70299-4","article-title":"Chorioretinal lesions in patients and carriers of chronic granulomatous disease","volume":"134","author":"Goldblatt","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2024.01.002_bib0800","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00006982-200306000-00012","article-title":"Chorioretinal lesions in patients with chronic granulomatous disease","volume":"23","author":"Kim","year":"2003","journal-title":"Retina Phila Pa"},{"key":"10.1016\/j.rmr.2024.01.002_bib0805","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2014.04.014","article-title":"Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease","volume":"134","author":"Magnani","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0810","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10875-011-9616-5","article-title":"Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease","volume":"32","author":"\u00c1lvarez-Cardona","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0815","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12887-020-1996-3","article-title":"Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review","volume":"20","author":"Wei","year":"2020","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.rmr.2024.01.002_bib0820","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/eci.12.98","article-title":"Pulmonary manifestations of chronic granulomatous disease","volume":"9","author":"Mahdaviani","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0825","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/520985","article-title":"Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease","volume":"45","author":"Siddiqui","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2024.01.002_bib0830","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.arcped.2018.09.003","article-title":"Fulminant mulch pneumonitis in a previously healthy child","volume":"25","author":"Maaloul","year":"2018","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.rmr.2024.01.002_bib0835","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1177\/0009922810370057","article-title":"Fulminant mulch pneumonitis in undiagnosed chronic granulomatous disease: a medical emergency","volume":"49","author":"Ameratunga","year":"2010","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.rmr.2024.01.002_bib0840","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.chest.2020.05.544","article-title":"A previously healthy 37-year-old man with acute hypoxic respiratory failure and fevers","volume":"158","author":"Axell-House","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2024.01.002_bib0845","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2214\/AJR.07.3482","article-title":"Chest radiographic and CT manifestations of chronic granulomatous disease in adults","volume":"191","author":"Godoy","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0850","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10875-019-00623-6","article-title":"Successful lung transplantation in a patient with chronic granulomatous disease","volume":"39","author":"Xie","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0855","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmr.2024.01.002_bib0860","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/978-1-62703-845-4_31","article-title":"Diagnostic assays for chronic granulomatous disease and other neutrophil disorders","volume":"1124","author":"Elloumi","year":"2014","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"10.1016\/j.rmr.2024.01.002_bib0865","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1126\/science.155.3764.835","article-title":"Leukocyte oxidase: defective activity in chronic granulomatous disease","volume":"155","author":"Baehner","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.rmr.2024.01.002_bib0870","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(96)90189-0","article-title":"Testing for chronic granulomatous disease","volume":"347","author":"Vowells","year":"1996","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.rmr.2024.01.002_bib0875","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1172\/JCI97116","article-title":"Inherited p40phox deficiency differs from classic chronic granulomatous disease","volume":"128","author":"van de Geer","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmr.2024.01.002_bib0880","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cei.12202","article-title":"Molecular diagnosis of chronic granulomatous disease","volume":"175","author":"Roos","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0885","unstructured":"CEREDIH [Internet]. [cit\u00e9 1\u00a0mars 2021]. Disponible sur\u00a0: https:\/\/www.ceredih.fr\/locations\/laboratories."},{"key":"10.1016\/j.rmr.2024.01.002_bib0890","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/jpids\/piy016","article-title":"Prevention of infectious complications in patients with chronic granulomatous disease","volume":"7","author":"Slack","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.rmr.2024.01.002_bib0895","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/infdis\/162.3.723","article-title":"Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease","volume":"162","author":"Margolis","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.rmr.2024.01.002_bib0900","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3476(89)80693-6","article-title":"Incidence, severity, and prevention of infections in chronic granulomatous disease","volume":"114","author":"Mouy","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.rmr.2024.01.002_bib0905","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-99-5-657","article-title":"Recent advances in chronic granulomatous disease","volume":"99","author":"Gallin","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmr.2024.01.002_bib0910","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2024.01.002_bib0915","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/myc.12573","article-title":"Phellinus species: an emerging cause of refractory fungal infections in patients with X-linked chronic granulomatous disease","volume":"60","author":"Haidar","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.rmr.2024.01.002_bib0920","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1086\/430068","article-title":"Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection","volume":"40","author":"Segal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2024.01.002_bib0925","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2024.01.002_bib0930","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bmt.1702651","article-title":"Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation","volume":"26","author":"Bielorai","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.rmr.2024.01.002_bib0935","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2017.02.026","article-title":"Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience","volume":"140","author":"Marciano","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0940","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1774-9987.2005.00227.x","article-title":"Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis","volume":"9","author":"Ikincio\u011fullari","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.rmr.2024.01.002_bib0945","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s10875-022-01261-1","article-title":"Granulocyte transfusions in patients with chronic granulomatous disease undergoing hematopoietic cell transplantation or gene therapy","volume":"42","author":"Arnold","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0950","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/INF.0b013e318218181d","article-title":"Corticosteroids in the treatment of severe nocardia pneumonia in chronic granulomatous disease","volume":"30","author":"Freeman","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.rmr.2024.01.002_bib0955","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clim.2013.03.004","article-title":"Thalidomide attenuates excessive inflammation without interrupting lipopolysaccharide-driven inflammatory cytokine production in chronic granulomatous disease","volume":"147","author":"Kawai","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0960","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/ajg.2009.56","article-title":"Thalidomide as a treatment for refractory CGD colitis","volume":"104","author":"Sokol","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0965","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2013.04.059","article-title":"Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series","volume":"132","author":"Noel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0970","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-020-00901-8","article-title":"Infections in patients with chronic granulomatous disease treated with tumor necrosis factor alpha blockers for inflammatory complications","volume":"41","author":"Conrad","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0975","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-015-0227-4","article-title":"Magnetic resonance imaging may be a valuable radiation-free technique for lung pathologies in patients with primary immunodeficiency","volume":"36","author":"Arslan","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0980","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10875-015-0172-2","article-title":"Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies","volume":"35","author":"Milito","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib0985","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1378\/chest.10-3147","article-title":"Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity","volume":"140","author":"Serra","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2024.01.002_bib0990","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/s41409-022-01739-x","article-title":"Curative allogeneic hematopoietic stem cell transplantation following reduced toxicity conditioning in adults with primary immunodeficiency","volume":"57","author":"Mar\u00e7ais","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.rmr.2024.01.002_bib0995","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"G\u00fcng\u00f6r","year":"2014","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.rmr.2024.01.002_bib1000","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3389\/fimmu.2020.01617","article-title":"Hematopoietic cell transplantation for chronic granulomatous disease in Japan","volume":"11","author":"Yanagimachi","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib1005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10875-019-00635-2","article-title":"Role of allogeneic hematopoietic stem cell transplant for Chronic Granulomatous Disease (CGD): a report of the United States Immunodeficiency Network","volume":"39","author":"Yonkof","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib1010","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/jpids\/piy015","article-title":"Allogeneic hematopoietic cell transplantation for chronic granulomatous disease: controversies and state of the art","volume":"7","author":"Connelly","year":"2018","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.rmr.2024.01.002_bib1015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10875-012-9758-0","article-title":"Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant","volume":"33","author":"Cole","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib1020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaci.2014.10.034","article-title":"Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease","volume":"135","author":"Fernandez-Boyanapalli","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib1025","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2010-02-272005","article-title":"PPAR\u03b3 activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease","volume":"116","author":"Fernandez-Boyanapalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rmr.2024.01.002_bib1030","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jaci.2016.01.033","article-title":"Pioglitazone as a novel therapeutic approach in chronic granulomatous disease","volume":"137","author":"Migliavacca","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2024.01.002_bib1035","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41467-022-28762-2","article-title":"A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders","volume":"13","author":"Tucci","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.rmr.2024.01.002_bib1040","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.rmr.2024.01.002_bib1045","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.rmr.2024.01.002_bib1050","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.stemcr.2019.08.008","article-title":"Targeted repair of p47-CGD in iPSCs by CRISPR\/Cas9: functional correction without cleavage in the highly homologous pseudogenes","volume":"13","author":"Klatt","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.rmr.2024.01.002_bib1055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41434-021-00251-z","article-title":"Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR\/Cas9\u00a0with 53BP1\u00a0inhibition for enhanced homology-directed repair","volume":"28","author":"Sweeney","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.rmr.2024.01.002_bib0530","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/sji.12621","article-title":"Phenotypic prenatal diagnosis of chronic granulomatous disease: a useful tool in the absence of molecular diagnosis","volume":"86","author":"Kulkarni","year":"2017","journal-title":"Scand J Immunol"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842524000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842524000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:25:03Z","timestamp":1760106303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842524000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0761842524000020"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2024.01.002","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications pulmonaires de la granulomatose septique chronique","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}